Compare ULBI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULBI | STRO |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.7M | 85.0M |
| IPO Year | 1995 | N/A |
| Metric | ULBI | STRO |
|---|---|---|
| Price | $5.75 | $20.45 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $18.88 |
| AVG Volume (30 Days) | 26.5K | ★ 116.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1166.67 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $164,456,000.00 | N/A |
| Revenue This Year | $31.30 | $63.08 |
| Revenue Next Year | $6.24 | N/A |
| P/E Ratio | $65.11 | ★ N/A |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $4.07 | $0.52 |
| 52 Week High | $9.51 | $20.59 |
| Indicator | ULBI | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 73.10 |
| Support Level | $5.42 | $0.76 |
| Resistance Level | $6.14 | N/A |
| Average True Range (ATR) | 0.27 | 1.70 |
| MACD | -0.07 | 0.27 |
| Stochastic Oscillator | 3.96 | 94.68 |
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.